NEVVI Medicare utilization intelligence
or

← back

Provider profile

AMIN, GIRISH MD

Hematology-Oncology · NPI 1720071731 · BRICK, NJ

1
Groups
50
Codes · 2024
209,190
Disclosed services

AMIN, GIRISH is a Hematology-Oncology in BRICK, NJ, a member of 1 medical group, who billed 50 distinct codes to Medicare Part B in 2024.

Groups: TITAN HEALTH PARTNERS LLC (EAST BRUNSWICK, NJ)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

209,190
disclosed services
50
codes billed to Medicare Part B
Prior year · CY2023 119,406 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J1756 Injection, iron sucrose, 1 mg
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
J1306 Injection, inclisiran, 1 mg
J0185 Injection, aprepitant, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1626 Injection, granisetron hydrochloride, 100 mcg
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J0640 Injection, leucovorin calcium, per 50 mg
96372 Injection of drug or substance under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
J9190 Injection, fluorouracil, 500 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J9045 Injection, carboplatin, 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
J1200 Injection, diphenhydramine hcl, up to 50 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3475 Injection, magnesium sulfate, per 500 mg
96361 Infusion into a vein for hydration, each additional hour
96375 Injection of additional new drug or substance into vein
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96416 Administration of prolonged chemotherapy into vein
96411 Administration of additional new drug or substance into vein using push technique
J7030 Infusion, normal saline solution , 1000 cc
96360 Infusion into a vein for hydration, 31-60 minutes
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3490 Unclassified drugs
96523 Irrigation of implanted venous access drug delivery device
99195 Drawing of blood for a medical problem
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.